Company
Anacalypsis Therapeutics
- Biotech
- Location:
- Spata, Greece
Description
Anacalypsis Therapeutics creates precision gene- and pathway-based therapeutic strategies, biomarkers, and genetically linked targets to alter neurodegenerative disease progression, detect Parkinson’s disease earlier, and tailor treatments for patients with brain and nervous system disorders.
Anacalypsis Therapeutics is located in the Athens ecosystem.
Related
BioArcticBioArctic develops therapeutics and related technologies for neurodegenerative disorders, focusing on disease-modifying treatments and…
BraineverBrainever develops hEN1 and hOTX2 homeoprotein drug candidates intended to limit neurodegenerative disease progression by preventing…
Herantis PharmaHerantis Pharma develops disease-modifying therapies designed to stop or reverse progression of neurodegenerative diseases, applying drug…
Molecular PartnersMolecular Partners develops DARPin therapeutics, including Radio-DARPins and logic-gated Switch-DARPins, to target DLL3, FAP x CD40, and…
OrganoTherapeuticsOrganoTherapeutics creates human iPSC-derived midbrain organoids, assembloids, and patient-specific Parkinson’s cell models, then provides…
PurposefulPurposeful repurposes marketed drugs to find treatments and develop pharmaceutical products for rare diseases, with an AI repurposing…
Synapsis LabsSynapsis Labs builds clinical-grade AI products for breast imaging, including Sentinel for mammography (DBT and MMG) and Nexus for breast…
RobeautéRobeauté develops a brain microrobotic platform for neuro-interventions, using rice-sized microrobots and related infrastructure to better…
ResQ BiotechResQ Biotech builds a living-cell discovery platform that biosynthesizes and functionally screens ultra-large libraries to identify…